RT Journal Article
SR Electronic
T1 Inflammatory bowel disease and the lung in paediatric patients
JF Breathe
JO Breathe
FD European Respiratory Society
SP 200269
DO 10.1183/20734735.0269-2020
VO 17
IS 1
A1 Jochmann, Anja
A1 Trachsel, Daniel
A1 Hammer, Jürg
YR 2021
UL http://breathe.ersjournals.com/content/17/1/200269.abstract
AB The prevalence of inflammatory bowel disease (IBD) has increased over the past 20 years. Pulmonary involvement in paediatric IBD is rare but may be missed since the spectrum of symptoms is broad and mimics other diseases. The most important differential diagnoses of pulmonary manifestations of IBD are infections and therapy-related side-effects. There is no gold standard to diagnose respiratory manifestations in children with IBD. Diagnostic tests should be chosen according to history and clinical presentation. Treatment of respiratory manifestations of IBD includes inhaled or oral corticosteroids and initiation or step-up of immunomodulatory IBD therapies.Pulmonary involvement in paediatric IBD is rare but may be underdiagnosed. The spectrum of symptoms is broad and mimics other diseases. The differentiation between IBD-related and drug-induced pulmonary manifestation can be challenging. https://bit.ly/3uZBvpA